Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Change in Accured Expenses (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Change in Accured Expenses data on record, last reported at $227000.0 in Q4 2019.

  • For Q4 2019, Change in Accured Expenses rose 176.69% year-over-year to $227000.0; the TTM value through Dec 2019 reached $226000.0, down 43.78%, while the annual FY2024 figure was $2.5 million, 615.23% up from the prior year.
  • Change in Accured Expenses reached $227000.0 in Q4 2019 per DMAC's latest filing, up from $195000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $409000.0 in Q3 2018 and bottomed at -$296000.0 in Q4 2018.